Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

The "Pharmaceutical Cold Chain Packaging Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ResearchAndMarkets.com's offering.The Global ...

DOPE-Cx can form a special structure called a "cubic phase," which helps overcome a major challenge in mRNA delivery by LNPs ... with specific hydrophobic chain structures induce non-lamellar ...

Dr Wiklund added that mRNA vaccines require cold chain storage, so aren’t ideal for use in more difficult locations. He explained: “For more permanent pathogens, for example, polio or measles ...

Shipping and logistics giant DHL Group is earmarking 2 billion euros ($2.2 billion) to bulk up its healthcare supply chain ...

Spray-drying represents a well-established technique that addresses solubility and other manufacturing and stability challenges.

German biotech Ethris, a company developing RNA therapeutics and vaccines, and Swiss contract development and manufacturing ...

They found that mRNA-based COVID-19-vaccinations cause a significant and persistent change through acetylation, i.e., the binding of a chemical group to specific, immunologically relevant genes of ...

Ethris, a clinical-stage biotechnology company creating RNA therapeutics and vaccines, and Lonza entered a collaboration to ...

Researchers have discovered that mRNA-based COVID-19 vaccines have a persistent effect on the innate immune system. These mechanisms may help the human body to better protect itself against ...